The Clinical Efficacy and Cardiotoxicity of Fixed-Dose Monthly Trastuzumab in HER2-Positive Breast Cancer: A Single Institutional Analysis

• Yi-Ying Wu ,

  Contributed equally to this work with: Yi-Ying Wu, Tzu-Chuan Huang

  Affiliations Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China, Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan, Republic of China

  ⨯
• Tzu-Chuan Huang ,

  Contributed equally to this work with: Yi-Ying Wu, Tzu-Chuan Huang

  Affiliation Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Tsung-Neng Tsai,

  Affiliations Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan, Republic of China, Division of Cardiology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Jia-Hong Chen,

  Affiliations Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan, Republic of China

  ⨯
• Ming-Shen Dai,

  Affiliation Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Ping-Ying Chang,

  Affiliation Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Ching-Liang Ho,

  Affiliation Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Ren-Hua Ye,

  Affiliation Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Tsai-Rong Chung,

  Affiliation National Institute of Cancer Research, Miaoli County, Taiwan, Republic of China

  ⨯
• Yeu-Chin Chen,

  Affiliation Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, Taipei City, Taiwan, Republic of China

  ⨯
• Tsu-Yi Chao

  * E-mail: 10575@s.tmu.edu.tw

  Affiliations Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan, Republic of China, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan, Republic of China, Division of Hematology and Oncology, Department of Medicine, Taipei Medical University, Shuang-Ho Hospital, New Taipei City, Taiwan, Republic of China

  ⨯